Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kinetics of host immune responses and cytomegalovirus resistance in a liver transplant patient.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Oct 2009

Schaffer Kirsten, Moran Julie, Duffy Margaret, McCormick Aiden P, Hall William W, Hassan Jaythoon

Abstract excerpt

Among solid organ transplant (SOT) recipients, donor-seropositive/recipient-seronegative (D+/R-) cytomegalovirus (CMV) status is associated with the highest risk of ganciclovir-resistant CMV disease, which has been reported for patients receiving oral ganciclovir but not valganciclovir prophylaxi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Cytomegalovirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytomegalovirus Infections

Share to Ganciclovir

Share to Immune System

Share to Immunosuppressive Agents

Share to Liver Diseases

Share to Liver Transplantation

Source

Identifiers

PMID: 19790144
DOI: 10.1002/lt.21832

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19790144-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kinetics of host immune responses and cytomegalovirus resistance in a liver transplant patient.PMID 19790144Read ↗

Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.Semantic proximity Read ↗

Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.Semantic proximity Read ↗

The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection.Semantic proximity Read ↗

The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.Semantic proximity Read ↗

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.Semantic proximity Read ↗

Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.Semantic proximity Read ↗

The biology of cytomegalovirus drug resistance.Semantic proximity Read ↗

Epidemiology and Outcome of Ganciclovir-Resistant Cytomegalovirus Infection After Solid Organ Transplantation: A Single Transplant Center Experience in Thailand.Semantic proximity Read ↗

Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load.Semantic proximity Read ↗

Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.Semantic proximity Read ↗

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.Semantic proximity Read ↗

Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.